Document Detail


Changes in functional expression of alpha-1 adrenoceptors in hindlimb vascular bed of spontaneously hypertensive rats and their effects on oxygen consumption.
MedLine Citation:
PMID:  9694909     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Norepinephrine (NE) induces a sigmoidal dose-response curve for perfusion pressure and a bell-shaped curve for oxygen consumption (VO2) in the constant-flow perfused hindlimb of Wistar rats. These effects are now described in spontaneously hypertensive rats (SHR) and age-matched Wistar-Kyoto rats (WKY). In SHR, the pressure curve was shifted left- and upward whereas the VO2 curve was shifted left- but downward, when compared with WKY. In the presence of 10 microM propranolol, prazosin (2.5 nM) shifted the pressure and VO2 curves much more than yohimbine (0.1 microM) to the right in both strains and its effects were greater in SHR, suggesting that these effects were mediated largely by alpha-1 receptors, particularly in SHR. In the presence of propranolol plus yohimbine, the pressure curve was markedly shifted to the right by both the selective alpha-1A-antagonist 5-methylurapidil (3.3 nM), and by the alpha-1D antagonist BMY 7378 (0.1 microM) or SK&F 105854 (2 microM) in SHR but not in WKY. With respect to the VO2 curve, 5-methylurapidil attenuated the descending limb without affecting the ascending limb. Similar effects were also obtained with another alpha-1A antagonist 1 nM KMD-3213 in both SHR and WKY. In contrast, BMY and SK&F markedly inhibited the ascending limb of the VO2 curve. These results indicate that both alpha-1A- and alpha-1D subtypes are functionally up-regulated in SHR muscle vascular bed where the ascending limb of VO2 is predominantly mediated by the alpha-1D at a much lower concentration for NE than the descending limb which is predominantly mediated by the alpha-1A subtype.
Authors:
J M Ye; E Q Colquhoun
Related Documents :
19521419 - Prevention and regression of hypertension: role of renal microvascular protection.
6658939 - Differential outcome to middle cerebral artery occlusion in spontaneously hypertensive ...
1270509 - Support of cardiac performance following heart valve surgery by raising heart rate to t...
9829619 - Inhibitory effect of tranilast on hypertrophic collagen production in the spontaneously...
8490329 - Evidence for reduced cancellous bone mass in the spontaneously hypertensive rat.
8948009 - Enduring effects of infant feeding experiences on adult blood pressure.
465279 - Interaction of atenolol and adrenaline with respect to intraocular pressure.
11941069 - Intraocular pressure changes in nonglaucomatous patients undergoing electroconvulsive t...
6336719 - Systolic time intervals as possible predictors of pressure response to sustained beta-a...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The Journal of pharmacology and experimental therapeutics     Volume:  286     ISSN:  0022-3565     ISO Abbreviation:  J. Pharmacol. Exp. Ther.     Publication Date:  1998 Aug 
Date Detail:
Created Date:  1998-09-02     Completed Date:  1998-09-02     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0376362     Medline TA:  J Pharmacol Exp Ther     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  599-606     Citation Subset:  IM    
Affiliation:
Division of Biochemistry, School of Medicine, University of Tasmania, Hobart, Tasmania, Australia 7001.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic alpha-Agonists / pharmacology
Adrenergic alpha-Antagonists / pharmacology
Animals
Blood Pressure / drug effects,  physiology
Dose-Response Relationship, Drug
Hindlimb / blood supply
Hypertension / genetics*,  metabolism*
Male
Muscle, Smooth, Vascular / metabolism*
Norepinephrine / pharmacology
Oxygen Consumption / genetics*,  physiology*
Rats
Rats, Inbred SHR
Rats, Inbred WKY
Receptors, Adrenergic, alpha-1 / agonists,  antagonists & inhibitors,  biosynthesis*
Regional Blood Flow / physiology
Vasoconstriction / drug effects
Chemical
Reg. No./Substance:
0/Adrenergic alpha-Agonists; 0/Adrenergic alpha-Antagonists; 0/Receptors, Adrenergic, alpha-1; 51-41-2/Norepinephrine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Protean effects of a natural peptide agonist of the G protein-coupled secretin receptor demonstrated...
Next Document:  Alpha-1 adrenergic stimulation of glucose uptake in rat white adipocytes.